Export Recognition Paxman Scalp Cooling has been recently recognized as a Heroes of British Export at the 2025 Made in Britain Impact Awards, highlighting strong international credibility and potential for expanding distributor networks and hospital partnerships in export markets.

Acquisition Momentum Strategic growth through acquisition of Dignitana AB signals an aggressive expansion plan and increased market share in scalp cooling equipment, presenting cross-sell and upsell opportunities with existing distributors and healthcare facilities.

Global Partnerships Active collaboration with a broad network of global, regional, and local organizations suggests fertile ground for co-marketing, joint education programs, and expanded adoption through international health systems and conference initiatives.

Reimbursement Leverage History of Medicare/coverage developments and Buy and Build model indicates ongoing reimbursement enablement; target health plans, providers, and hospital procurement teams to accelerate insurer direct billing and clinic adoption.

Clinical Adoption Clinically proven, cost-effective solution with multiple patient-capable models positions Paxman as a scalable option for large chemotherapy clinics and hospitals seeking to reduce alopecia-related patient distress and improve treatment experience.